DexCom (DXCM) – Investment Analysts' Weekly Ratings U

DexCom (NASDAQ: DXCM) recently received a number of ratings updates from brokerages and research firms: 5/1/2024 – DexCom was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 4/26/2024 – DexCom had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a “strong-buy” rating […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Canada , United States , Kingswood , South Gloucestershire , Matthew Vincent Dolan , Raymond James , Jeremem Sylvain , Canaccord Genuity Group Inc , Fintrust Capital Advisors , News Ratings For Dexcom Inc Daily , Nasdaq , Citigroup Inc , Kingswood Wealth Advisors , Dexcom Inc , Commonwealth Equity Services , Cambridge Investment Research Advisors Inc , Securities Exchange Commission , Valeo Financial Advisors , Royal Bank , Canaccord Genuity Group , Com Stock Down , Get Free Report , Vincent Dolan , Exchange Commission , Financial Advisors , Equity Services , Investment Research Advisors , Wealth Advisors , Trust Capital Advisors , Dexcom Share , Dexcom Real Time , Dexcom Inc Daily , Nasdaq Dxcm , Dxcm ,